Skip to main content
Premium Trial:

Request an Annual Quote

Michael Cavanaugh, George Bers

Premium

Michael Cavanaugh has joined Laureate Pharma as vice president of sales, marketing, and business development, the Princeton, NJ-based company said last week.

Cavanaugh used to be vice president of marketing and sales support for North America with Amersham/GE Healthcare, where he was responsible for products that included instruments and reagents for genomics, proteomics, screening, cellular analysis, and preclinical imaging. Prior to that, he was senior director of business development Europe at Gene Logic. Cavanaugh holds a master's degree in clinical microbiology with a minor in biochemistry from Hahnemann Medical College in Philadelphia and a BS in biology with a minor in chemistry from Fairfield University, Conn.


George Bers has become executive vice president of commercial operations at Genospectra, a new position, the Fremont, Calif.-based company said last week.

Bers has previously held various senior executive management positions at NuGen, Beckman Coulter, Nanogen, and Bio-Rad Laboratories. He has an MS in biochemistry from Georgetown University and a BA from Duke University.


Correction

In the story "With Cellomics on Board, Fisher Enters Unfamiliar Territory to Compete in HCS," published in the 8/8/2005 issue of CBA News, several quotes from a Fisher investor conference call were mistakenly attributed to Paul Montrone, Fisher's chairman and CEO. In fact, Paul Meister, vice chairman of Fisher's board of directors, made the comments.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.